Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Formal

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
American Journal of Epidemiology|January 1, 1974
An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccinesM M Levine, P A Rice, E J Gangarosa, et al.
Vaccine|May 1, 1994
Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2D N Taylor, D F Phillip, M Zapor, et al.
Infection and Immunity|June 1, 1992
Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigenK L Kotloff, D A Herrington, T L Hale, et al.
Vaccine|April 1, 1995
Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2K L Kotloff, G A Losonsky, J P Nataro, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
American Journal of Epidemiology|January 1, 1974
An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccinesM M Levine, P A Rice, E J Gangarosa, et al.
Vaccine|May 1, 1994
Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2D N Taylor, D F Phillip, M Zapor, et al.
Infection and Immunity|June 1, 1992
Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigenK L Kotloff, D A Herrington, T L Hale, et al.
Vaccine|April 1, 1995
Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2K L Kotloff, G A Losonsky, J P Nataro, et al.
Pageof 12